BMC Infectious Diseases

Table 1 ICERs for all screening strategies

From: Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies

ICER (A) vs (B)		(B)
ICER (A) vs (B)		No screening	Basic Screening	Advanced Screening	Mixed Screening
(A)	Total population
	Basic Screening	5592 EUR
	Advanced Screening	6525 EUR	7116 EUR
	Mixed Screening	5590 EUR	5589 EUR	689 EUR
	Total Screening	7490 EUR	8257 EUR	10,258 EUR	21,801 EUR
	Subgroups
	General population
	Basic Screening	5322 EUR
	Advanced Screening	9635 EUR	13,481 EUR
	Total Screening	13,317 EUR	18,379 EUR	30,370 EUR
	PWID
	Basic Screening	7548 EUR
	Advanced Screening	3406 EUR	1838 EUR
	Total Screening	2240 EUR	1077 EUR	30 EUR
	MSM
	Basic Screening	− 8445 EUR^a
	Advanced Screening	−10,614 EUR^a	−14,962 EUR^a
	Total Screening	− 9796 EUR^a	−12,898 EUR^a	dominated^b

^a (A) dominates (B): less lost QALYs and lower costs in (A) compared to (B)
^b (A) dominated by (B): more lost QALYs and higher costs in total screening compared to advanced screening (ICER: -29,175 EUR)

Back to article page